Last updated: February 20, 2026
Remote patient monitoring devices in cardiology fall into three main groups that capture different cardiac and vital sign data. Cardiac Implantable Electronic Devices (CIEDs) such as pacemakers, ICDs, and implantable loop recorders provide continuous rhythm monitoring. Wearable devices like ECG patches and smart shirts offer non-invasive cardiac surveillance for days or weeks at a time. Physiological monitors including blood pressure cuffs, digital scales, and pulse oximeters track vital signs that are critical for heart failure and hypertension management. The cardiovascular diseases segment dominated the remote patient monitoring market with a 36.52% market share in 2025, driven by the high global burden of conditions that require frequent vital sign monitoring.
CardioMEMS is an FDA-approved implantable device for remote monitoring of pulmonary artery pressures in heart failure patients. The system transmits daily pressure readings through a patient pillow and flags early signs of heart failure exacerbation.
Medtronic's CIED portfolio includes pacemakers, ICDs, and CRT devices with built-in remote monitoring. These devices automatically transmit arrhythmia episodes, device diagnostics, and battery status to the CareLink portal.
Rhythm360 integrates Medtronic data through API and HL7 feeds and consolidates alerts with AI triage. This approach reduces response times by 80% while maintaining greater than 99.9% data transmissibility.
Abbott's CIED systems provide advanced arrhythmia detection algorithms and remote monitoring through the Merlin.net platform. These devices perform particularly well for atrial fibrillation detection and device tuning.
Omron offers FDA-cleared cellular-enabled blood pressure cuffs that automatically transmit readings for hypertension management. These devices fit RPM programs under CPT 99454 for physiological monitoring.
The Zio patch is a single-use adhesive ECG patch that provides continuous cardiac rhythm monitoring for up to 14 days. It works especially well for detecting intermittent arrhythmias such as paroxysmal atrial fibrillation.
Rhythm360 uses computer vision technology to ingest Zio reports through PDF parsing and merges findings with other cardiac data sources for a more complete patient assessment.
Apple Watch provides a consumer-grade wearable with FDA-cleared ECG capability and irregular rhythm notifications. It offers accessible cardiac monitoring for patients who already use Apple devices daily.
The Cordella system is recently FDA-approved for NYHA class III heart failure patients, implanted in 20 minutes and wirelessly transmitting pulmonary artery pressure data to help reduce hospital readmissions.
HeartBeam received FDA clearance for its 12-lead cable-free home ECG monitoring system. This system enables comprehensive cardiac assessment from a patient's home.
Rhythm360 integrates HeartBeam data through API connections and presents synthesized 12-lead ECGs alongside other cardiac monitoring data in a unified dashboard.
The Hexoskin Medical System smart shirt received FDA 510(k) clearance for long-term continuous ECG and respiratory monitoring. The system is designed specifically for remote patient care applications.
AccurKardia's AccurECG 2.0 received FDA clearance as Class II software for automated, near real-time ECG interpretation. The software supports beat-by-beat analysis and detects 13 rhythm classifications including atrial fibrillation and ventricular tachycardia.
Rhythm360 uses similar AI-powered analysis capabilities and provides automated ECG interpretation while connecting with multiple device manufacturers for complete cardiac monitoring workflows.
The CMS 2026 Physician Fee Schedule Final Rule, effective January 1, 2026, significantly lowered RPM time thresholds. Device supply and data transmission are now billable for 2-15 days or 16-30 days in a 30-day period, compared to the previous 16+ day requirement. New CPT code 99470 allows billing for remote physiologic monitoring treatment services for the first 10 minutes with real-time interactive communication, reimbursing approximately $26.
Key 2026 Medicare RPM coverage includes CPT 99454 for remote monitoring of physiologic parameters at approximately $47 for 16-30 days of monitoring and CPT 93298/93299 for CIED remote monitoring. All Medicare beneficiaries are eligible for RPM services, which requires FDA-defined medical devices, patient opt-in, and HIPAA-compliant data transmission. Rhythm360 automates compliant billing documentation and CPT code capture and helps practices recover previously lost revenue and increase profitability by up to 300%.
Schedule a demo to see how Rhythm360 supports your Medicare RPM reimbursement strategy.
Primary challenges include data overload from high transmission volumes, where only 6.6% of CIED transmissions require clinical action, which overwhelms teams and drives alert fatigue. Poor integration into existing care pathways, unclear clinical responsibility, and interoperability gaps create additional barriers to effective RPM programs.
Data fragmentation across multiple OEM portals forces clinical staff to log into separate systems for Medtronic, Abbott, Boston Scientific, and Biotronik devices. This fragmentation increases administrative burden and raises the risk of missed critical events. Solutions include summarization of alerts by qualified cardiac technicians, automation, and AI that focus on true positive alerts and streamline workflows.
Rhythm360 addresses these challenges with a vendor-neutral platform that consolidates all cardiac device data into a single dashboard. The AI-powered alert triage system cuts response times for critical events by 80%, and redundant data feeds maintain greater than 99.9% transmissibility even when OEM servers experience downtime. Integration with Epic, Cerner, and other EHR systems removes manual data entry and gives clinicians a complete patient view.
Platform | Vendor-Neutral | Alert Reduction | Revenue Boost | EHR Integrations |
Rhythm360 | Yes | 80% | 300% | Epic, Cerner |
Paceart | No | Minimal | Low | Limited |
PaceMate | Partial | 50% | 100% | Some |
Murj | Partial | 60% | 150% | Partial |
Implicity | Yes | ~58% | 200% | Epic |
Remote patient monitoring for heart failure uses continuous tracking of parameters such as weight, blood pressure, and pulmonary artery pressures. Devices include digital scales, blood pressure monitors, and implantable sensors like CardioMEMS. These systems flag early heart failure exacerbations so clinicians can adjust medications and intervene before hospitalization. Rhythm360 unifies data from multiple heart failure monitoring devices into one platform and provides clinicians with status updates and automated alert prioritization.
The strongest RPM platforms in 2026 focus on vendor-neutral integration, AI-based alert management, and deep EHR connectivity. Rhythm360 leads in vendor-neutral capabilities and consolidates data from all major cardiac device manufacturers while delivering 80% faster alert response times and 300% revenue increases through streamlined billing workflows. Other notable platforms include Implicity for AI-driven filtering and Murj for workflow automation, although they provide more limited integration compared with Rhythm360's broader approach.
CIED remote monitoring devices include pacemakers, ICDs, CRT devices, and implantable loop recorders from manufacturers such as Medtronic, Abbott, Boston Scientific, and Biotronik. These devices automatically transmit arrhythmia episodes, device diagnostics, battery status, and lead impedance data to manufacturer-specific portals. Rhythm360 connects with all major CIED manufacturers through API connections, HL7 feeds, and computer vision technology and removes the need for clinicians to access multiple portals while preserving comprehensive data capture and analysis.
Medicare covers remote cardiac monitoring through several CPT codes that apply in 2026. CPT 93298 covers CIED remote monitoring services, and CPT 99454 covers remote physiological monitoring for parameters such as blood pressure and weight. The 2026 updates lowered time thresholds and make it easier to qualify for reimbursement with monitoring periods as short as 2-15 days. New CPT 99470 supports billing for 10-minute clinical interactions and expands coverage options for cardiac practices that run RPM programs.
Remote patient monitoring devices for cardiology include implantable devices such as pacemakers, ICDs, and pressure sensors, wearable monitors such as ECG patches, smart shirts, and smartwatches, and physiological monitoring tools such as blood pressure cuffs, digital scales, and pulse oximeters. Each category serves specific clinical needs. Implantable devices provide continuous cardiac rhythm monitoring. Wearables offer non-invasive cardiac surveillance. Physiological monitors track vital signs that are essential for chronic disease management. The choice depends on patient condition, monitoring duration, and clinical goals.
FDA-approved wearable RPM devices include the Hexoskin Medical System smart shirt for continuous ECG and respiratory monitoring, Zio ECG patches for extended cardiac rhythm surveillance, and HeartBeam's cable-free 12-lead ECG system for home-based cardiac assessment. Apple Watch received FDA clearance for ECG capability and irregular rhythm notifications, and AccurKardia's AccurECG 2.0 provides device-agnostic ECG interpretation software. These devices offer different levels of clinical accuracy and monitoring depth, and medical-grade devices usually provide more comprehensive data for clinical decision-making.
The remote patient monitoring device landscape for cardiology continues to expand in 2026 as new FDA clearances and improved Medicare reimbursement create strong opportunities for practice growth. Success still depends on solving data fragmentation across multiple device manufacturers and monitoring platforms.
Rhythm360 turns disparate RPM devices into a unified cardiac monitoring ecosystem and consolidates CIEDs, heart failure sensors, and physiological monitors into a single intelligent platform. By cutting alert fatigue by 80% and increasing revenue capture by 300%, Rhythm360 helps cardiology practices improve both clinical outcomes and financial performance from their RPM investments.
Schedule a demo today to see how Rhythm360 can unify your remote patient monitoring devices and strengthen your cardiac care delivery.
